← Latest papers
🧬 biology

Quasispecies variation of 5’ half-length genomes from HIV-1 CRF103_01B by single genome amplification

This study utilized single-genome amplification to characterize the intra-host quasispecies variation and minority drug resistance of HIV-1 CRF103_01B in Beijing MSM, providing insights into viral heterogeneity and its potential impact on antiretroviral therapy efficacy.

Original authors: Man Dai, Jia Li, Xiyao Li, Mingfeng Xiao, Huixuan Wang, Ruolei Xin

Published 2026-08-31
📖 5 min read🧠 Deep dive

Original authors: Man Dai, Jia Li, Xiyao Li, Mingfeng Xiao, Huixuan Wang, Ruolei Xin

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Viruses are not static invaders; they are shifting populations that change as they move through a host. When a person is infected with HIV, the virus does not exist as a single, uniform entity. Instead, it exists as a cloud of slightly different genetic versions, a collection known as a quasispecies. Think of this cloud like a deck of cards where every card is almost identical to the others, but each has a tiny, unique mark. Because the virus replicates so quickly and makes frequent copying errors, these marks accumulate. In the early days of an infection, the deck is usually very uniform, but as time passes and the body's immune system fights back, the virus evolves, creating a more complex and diverse deck. Understanding this diversity is critical because some of these rare, hidden variants might carry traits that allow them to survive medication, even if the majority of the virus population does not.

A team of researchers in Beijing set out to examine this hidden diversity within a specific strain of HIV known as CRF103_01B. This strain was first identified in 2020 among men who have sex with men in Hebei Province, but further tracing revealed it originated in Beijing and had been circulating there since at least 2017. While scientists had previously mapped the broad structure of this virus, they lacked a detailed look at the individual genetic variations within the people carrying it. To see these subtle differences, the researchers turned to a technique called single-genome amplification. Unlike standard methods that mix all the viral copies together and produce an average result, this method isolates and copies individual viral genomes one by one. This allows scientists to see the rare variants that might be missed by other approaches, revealing the true complexity of the viral population inside each patient.

The study focused on six individuals living in Beijing who were infected with this specific strain. None of them had received treatment for HIV at the time of the study, which meant the researchers could observe the virus in its natural state without the influence of medication. The group included five men and one woman, ranging in age from 26 to 50. Some had been living with the virus for many years, while one man was diagnosed very recently, representing an acute infection. The researchers collected blood samples from these six people and extracted the viral RNA. Using the single-genome amplification technique, they successfully generated a total of 164 distinct genetic sequences from the 5' half of the viral genome, with between 21 and 36 sequences obtained for each person, capturing a detailed snapshot of the viral cloud within each host.

When the researchers analyzed these sequences, the results revealed a clear difference between the early and late stages of infection. The individual with the acute infection, who had only recently contracted the virus, showed a remarkably uniform viral population. The genetic sequences from this person were nearly identical, suggesting that the infection was started by a single viral strain or a group of very closely related strains. This finding aligns with the idea that sexual transmission often involves a genetic bottleneck, where only a few variants successfully establish the infection. In contrast, the five individuals with chronic, long-term infections displayed a much more complex picture. Their viral populations had split into several distinct subgroups, showing that the virus had evolved significantly over time, adapting to the host's immune system and creating a diverse mix of genetic variants.

The study also uncovered a specific pattern in a married couple among the participants, a man and a woman who were both infected. Their viral sequences formed a tight cluster, confirming they were part of the same transmission chain. However, the woman's viral population was less diverse than the man's, and her virus formed a single secondary evolutionary cluster with strong statistical support, whereas the man's virus showed multiple subclusters. This pattern, combined with the fact that the man had a much lower immune cell count at diagnosis, strongly suggested that he was the source of the infection and that she had been infected later in the course of his disease. The virus in the man had had more time to evolve and diversify, while the woman's virus remained closer to the original strain that passed between them.

Beyond the evolutionary history, the researchers looked for signs of drug resistance, which are mutations that could make standard treatments less effective. Surprisingly, none of the 164 sequences showed signs of resistance that would be detected by standard, bulk testing methods. However, the single-genome approach revealed a different story. Every single sequence carried a specific mutation known as V106I, which is associated with reduced sensitivity to a class of drugs called non-nucleoside reverse transcriptase inhibitors. Furthermore, the researchers found several other rare mutations in small percentages of the viral population within individual patients. For instance, one patient carried a mutation called F227Y in nearly 18 percent of his viral variants, and others carried mutations like I50V and L210W at very low frequencies. These mutations were invisible to traditional testing but were clearly present in the viral cloud.

The presence of these minority variants is significant because they can act as a reservoir for future treatment failure. If a patient starts a medication regimen that targets the main viral population, these rare, pre-existing variants might survive and multiply, eventually causing the treatment to stop working. The study highlights that relying on standard tests might give a false sense of security regarding drug resistance. By using single-genome amplification, the researchers demonstrated that even in people who have never taken HIV medication, the virus can harbor hidden genetic variations that could compromise therapy. This detailed view of the viral quasispecies offers a more accurate way to understand how HIV evolves within a person and suggests that looking deeper into these genetic clouds could help doctors design better, more personalized treatment plans from the very start.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →